Gilead's HIV drugs beat Glaxo rival in comparison study

home   >   blogdigger

Biopharmaceutical firm Gilead Sciences has presented 24-week data from an ongoing clinical trial suggesting that a regimen of Gilead HIV drugs Viread and Emtriva, and efavirenz, demonstrates greater efficacy than a regimen of GlaxoSmithKline's Combivir and efavirenz.

- link to Gilead's HIV drugs beat Glaxo rival in comparison study -
Last update: 05/26/2005

Recommended Reading

    Drug update: Anemia. : An article from: Family Practice News
    NEW DRUGS: A DOSE OF REALITY. : An article from: Columbia Journalism Review
    Prevacid for GERD is approved for children. (Proton-Pump Inhibitor).(gastroesophageal reflux disease)(Brief Article) : An article from: Pediatric News
    COX-2 Inhibitors Are 'Safer Aspirins,' Not 'Superaspirins'.(Brief Article) : An article from: Family Practice News
    Remission rates shown higher with venlafaxine than SSRIs: major depression.(selective serotonin reuptake inhibitors)(Psychopharmacology) : An article from: Clinical Psychiatry News
    Advair Diskus throws GSK into the forefront: GlaxoSmithKline makes effective use of robotics to produce the No. 1 asthma inhaler.(Plants of the year: ... ine) : An article from: Food & Drug Packaging
    Remicade.(Brief Article) : An article from: Family Practice News
    Crushed dreams: doctors use drugs to heal, but in the wrong hands, drugs can wreck lives.(Close-Up: Medications) : An article from: Scholastic Choices